Needham Maintains Buy on Boston Scientific, Raises Price Target to $65
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson maintains a 'Buy' rating on Boston Scientific (NYSE:BSX) and raises the price target from $61 to $65.
September 21, 2023 | 10:37 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Mike Matson maintains a 'Buy' rating on Boston Scientific and raises the price target from $61 to $65.
The raised price target by Needham analyst Mike Matson indicates a positive outlook for Boston Scientific. This could potentially lead to an increase in the stock price in the short term as it suggests that the stock is undervalued at its current price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100